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Candida parapsilosis is an opportunistic human fungal pathogen that poses a serious
threat to low birth weight neonates, particularly at intensive care units. In premature
infants, the distinct immune responses to Candida infections are not well understood.
Although several in vivo models exist to study systemic candidiasis, only a few are
available to investigate dissemination in newborns. In addition, the majority of related
studies apply intraperitoneal infection rather than intravenous inoculation of murine
infants that may be less efficient when studying systemic invasion. In this study, we
describe a novel and conveniently applicable intravenous neonatal mouse model to
monitor systemic C. parapsilosis infection. Using the currently developed model, we
aimed to analyze the pathogenic properties of different C. parapsilosis strains. We
infected 2 days-old BALB/c mouse pups via the external facial vein with different doses
of C. parapsilosis strains. Homogenous dissemination of yeast cells was found in the
spleen, kidney, liver and brain of infected newborn mice. Colonization of harvested
organs was also confirmed by histological examinations. Fungal burdens in newborn
mice showed a difference for two isolates of C. parapsilosis. C. parapsilosis CLIB
infection resulted in higher colonization of the spleen, kidney and liver of neonatal
mice compared to the C. parapsilosis GA1 strain at day 2 after the infection. In a
comprehensive study with the adult mice infection, we also presented the attenuated
virulence of a C. parapsilosis cell wall mutant (OCH1) in this model. Significantly less
och11/1 null mutant cells were recovered from the spleen, kidney and liver of newborn
mice compared to the wild type strain. When investigating the cytokine response of
neonatal mice to C. parapsilosis infection, we found elevated TNFα, KC, and IL-1β
expression levels in all organs examined when compared to the uninfected control.
Furthermore, all three measured cytokines showed a significantly elevated expression
when newborn mice were infected with och11/1 cells compared to the wild type strain.
This result further supported the inclusion of OCH1 in C. parapsilosis pathogenicity. To
our current knowledge, this is the first study that uses a mice neonatal intravenous
infection model to investigate C. parapsilosis infection.
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INTRODUCTION
Candida species are common agents causing invasive diseases
in neonates (Stoll et al., 2002; Benjamin et al., 2006; Chow
et al., 2012). Although the incidence of invasive fungal infections
among premature infants in neonatal intensive care units
(NICUs) has decreased during the past decade (Aliaga et al., 2014;
Kelly et al., 2015), candidiasis and infection-related death is still
of major concern (Le et al., 2013).
Previously, epidemiological reports have demonstrated the
difference in the range of infections caused by Candida species
(Dotis et al., 2012; Juyal et al., 2013; Jordan et al., 2014). While
Candida albicans is the leading cause of invasive candidiasis in
general, children under the age of 2 are at greater risk of infections
caused by C. parapsilosis, an emerging non-albicans Candida
species (Dotis et al., 2012; Juyal et al., 2013; Jordan et al., 2014).
Neonatal animal injection methods have been in use for
more than 30 years with the purpose of modeling newborn
diseases (Billingham and Silvers, 1961; Pope et al., 1979; Domer,
1988; Chen et al., 1989; Rodewald et al., 1992; Tang et al., 1996;
Genovese et al., 1999; Venkatesh et al., 2007; Trofa et al., 2011;
Tsai et al., 2011). These models proved to be excellent for
studying Escherichia coli- (Cox and Taylor, 1990), Pseudomonas
aeruginosa- (Tang et al., 1996), Listeria monocytogenes- (Chen
et al., 1989; Genovese et al., 1999), and Streptococcus- (Rodewald
et al., 1992) caused sepsis in neonate mice and analyzing the
virulence factors of these pathogens or the possible treatment of
invasive diseases. Also, the neonate animal models have proven to
be efficient to study newborn-related Candida infections (Pope
et al., 1979; Domer, 1988; Venkatesh et al., 2007; Trofa et al.,
2011; Tsai et al., 2011). Early studies laid foundations to establish
systemic candidiasis in newborn mice by gastric inoculation
(Pope et al., 1979; Domer, 1988). Using-2-day old mouse pups,
the intraperitoneal route of injection was used to demonstrate the
disseminated infection and assessing virulence properties of the
different C. albicans strains, including comparisons of survival
proportions or the extent of organ colonization (Tsai et al., 2011).
Trofa et al. (2011) provided the first report of C. albicans and
C. parapsilosis infection in a neonatal rat model. This research
also demonstrated the crucial role of the secreted lipases in the
virulence of these species. The study concluded that preterm
rodents show higher susceptibility to Candida infections and
confirmed the utility of neonatal animal models to characterize
C. parapsilosis pathogenesis.
In newborn mice, gastric or intraperitoneal inoculation
has previously been carried out as a route of infection to
model systemic candidiasis (Pope et al., 1979; Domer, 1988;
Venkatesh et al., 2007; Tsai et al., 2011). However, these
models still have several limitations. The colony counts have
shown considerable variation between the already mentioned
inoculation methods. Gastric infection of infant mice led
to rapid transmission of C. albicans cells from the gut to
the liver, and less frequently to other organs such as the
kidneys and spleen (Pope et al., 1979; Domer, 1988). Following
peritoneal injection, strong spleen attachment occurred, either
by direct contact with the organ or through lymphatic channels
(Tsai et al., 2011).
Systemic infection models in neonatal mice are valuable tools
for studying severe newborn diseases (Vizler et al., 1993; Kienstra
et al., 2007; Glascock et al., 2011). In this study, we introduce
a new intravenous neonatal mouse model of C. parapsilosis
infection, which could help to understand the complications in
the response of the premature immune system to the systemic
fungal invasions.
MATERIALS AND METHODS
Ethics Statement
All animal experiments were performed by national (1998.
XXVIII; 40/2013) and European (2010/63/EU) animal ethics
guidelines. The experimental protocols were approved by the
Animal Experimentation and Ethics Committee of the Biological
Research Centre of the Hungarian Academy of Sciences and the
Hungarian National Animal Experimentation and Ethics Board
(clearance number: XVI./03521/2011.) with the University of
Szeged granted permission XII./00455/2011 and XVI./3652/2016
to work with mice.
Candida Strains
Candida parapsilosis GA1 (SZMC 8110) (Gacser et al., 2005),
CLIB 214 (SZMC 1560) (Laffey and Butler, 2005) wild-type
strains and C. parapsilosis och11/1 (Perez-Garcia et al., 2016)
and C. parapsilosis och11/1+OCH1 (Perez-Garcia et al., 2016)
were used in this study. Candida cells were grown overnight
at 30◦C in liquid YPD medium (1% yeast extract, 2% peptone,
and 2% glucose). Before experiments, cells were harvested
by centrifugation, washed twice with PBS (phosphate-buffered
saline; 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM
KH2PO4; pH 7.4) and counted using a hemocytometer.
C. parapsilosis Intravenous Infection
Timed pregnant BALB/c mice were obtained in the specific
pathogen-free animal facility of the Biological Research Center
(BRC, Szeged, Hungary, XVI./2015.). Mice were monitored to
determine the date of the nativity. They received commercial
mouse food pellets and water ad libitum. On a post-partum
day 2, mouse pups were weighed (weight of pups was around
2,2-2,7 g depending on the number of pups in the same litter)
and randomized within cages prior the injection with 1 × 107
or 2x107 yeast cells/20 µl of C. parapsilosis strains or with
sterile PBS (control). Briefly, the injection of newborn mice was
performed with a 1 ml insulin syringe with 30 G X 8 mm
needle via the external facial vein of newborn mice. Bubbles
in the suspension were eliminated to prevent potentially lethal
air emboli. The vein was visualized by transilluminating the
head with a light source placed on the opposite side. After
injection, pups were examined daily. At the indicated time-
points, pups were sacrificed via decapitation for the analysis
of fungal burden, cytokine response and histology. Adult mice
data were previously published (Perez-Garcia et al., 2016). 10–
12 weeks-old male BALB/c mice were injected via lateral tail
vein with 2 × 107yeast cells/100 µl of C. parapsilosis strains or
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FIGURE 1 | Intravenous infection of C. parapsilosis via injecting external facial vein of newborn mice. Transillumination of the head optimized the visualization of the
blood vessel. Black arrow shows the target vein (1). After the insertion of the needle, the slow clearance of the vein from the blood is visible upon the expelling of the
Candida suspension (2,3). White arrow shows the blanching of the vessel from blood (4). After the injection, the needle was withdrawn, and the blood returned to the
vascular space (5,6).
FIGURE 2 | Fungal burden in neonatal mice after wild-type C. parapsilosis
strain infection. CFU in spleen, kidney, liver and brain in newborn mice after 2
and 7 days of post-infection. At least n = 4 mice/group/experiment were
infected with the 1 × 107/20 µl of C. parapsilosis CLIB 214 (WT CLIB)
wild-type strain. Results (mean ± SEM) are pooled data from two independent
experiments. Not significant (ns), ∗p < 0.05 and ∗∗∗∗p < 0.0001 when the
CFUs were compared between the two-time points of the analysis as
determined by Mann–Whitney U test.
with sterile PBS (control). They were terminated at the same
time-points as pups.
Fungal Burden
For the colony counts, kidneys, spleens, livers, and brains were
collected, weighed, and homogenized in sterile PBS (in the case
of the kidney, in sterile PBS containing one Complete Protease
Inhibitor Tablet (Santa Cruz Biotechnology Lot.: J1012) per
50 ml). Homogenates were used for determination of fungal
burdens by colony counting after plating serial dilutions on
YPD agar plates per tissue. The CFUs were counted after 48 h
of incubation at 30◦C and expressed as CFU/g tissue. (No
colonies were recovered from samples from mice challenged with
PBS alone.) The remaining homogenates were centrifuged at
3000 rpm, 4◦C, for 15 min, and the supernatants were stored
at –20◦C until cytokine measurement.
Cytokine Measurement
TNFα, IL-1β, IL-10, and KC levels were determined by
commercial ELISA kits (R&D Systems) according to the
manufacturer’s instructions. Cytokine levels were measured from
kidney and liver of C. parapsilosis-infected (1 × 107 yeast
cells/20 µl) and PBS control mice after 2 and 7 days of infection.
The concentration of each cytokine was determined in units of
pg/ml, and then recalculated as pg/g tissue in the sample.
Histology
Whole spleens, kidneys, livers and brains of PBS control and
C. parapsilosis-infected (2× 107 yeast cells/20 µl) mice were fixed
and kept in 4% buffered formalin until processed for histology.
Fixed organs were sectioned and stained with periodic acid-Schiff
(PAS) using conventional staining methods. Tissue sections were
analyzed with a BX51 OLYMPUS or Zeiss Imager Z1 microscope.
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FIGURE 3 | Histopathology during systemic C. parapsilosis infection in neonate mice. Sections were stained with periodic acid-Schiff (PAS) stain. (A) Spleen, (B)
kidney, (C) liver, and (D) brain show the organs from PBS-injected mice. Fungal cells (indicated by arrowheads) are present in the organs of mice infected with the
2 × 107/20 µl C. parapsilosis CLIB 214 (WT CLIB) (E, spleen, F, kidney, G, liver, H, brain) wild-type strain. All observations were performed at day 2 post-infection.
Scale bar represents 100 µm.
FIGURE 4 | In vivo cytokine response in neonate mice after wild-type C. parapsilosis infection. TNFα, IL-1β, and KC level in the kidney (A) and liver (B) after 2 and 7
day of post-infection. Newborn mice were infected with the dose of 1 × 107/20 µl C. parapsilosis CLIB 214 (WT CLIB) strain or with 20 µl of PBS (control group,
ctrl). Results (mean ± SEM) are pooled data from at least two independent experiments (at least 4 mice/group/experiment). Not significant (ns), ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001 when it was compared to the control group and determined by unpaired t-test.
Statistical Analysis
Statistical analysis was performed using the GraphPad Prism 7
software. Differences in fungal burden were determined using
the Mann–Whitney U-test. Unpaired t-test was used for analysis
of cytokine measurements. Differences between groups were
considered significant at p-values of <0.05. The majority of
the experiments were performed at least twice and at least 4
mice/group/time point/experiment. Data are presented as means
with standard errors of the means (SEM).
RESULTS
Characterization of the Intravenous
C. parapsilosis Infection of Newborn
Mice
In this research, we aimed to develop a new neonatal mouse
model of invasive C. parapsilosis infection, using intravenous
infection through the external facial vein. This method was
originally developed for the adoptive transfer of hemopoietic
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cells (Billingham and Silvers, 1961). Figure 1 shows the method
of intravenous infection. Following transillumination of the
pups’ head to aid the visualization of the vascular anatomy, the
injection of newborn mice was performed via the external facial
vein. BALB/c mouse pups were injected on post-partum day
2 with PBS (control) or wild-type C. parapsilosis (WT CLIB)
(1× 107 yeast cells/20 µl).
To monitor the course of the infection in this neonatal model,
we included an early (day 2 post-infection) and a late (day 7
post-infection) time point examination. Fungal burdens were
detectable in the examined organs (kidney, spleen, liver, brain)
on day 2, indicating homogenous dissemination of C. parapsilosis
cells. The highest number of CFUs was detected in the liver on
day 2. Therefore, the injection via the external facial vein was not
associated with higher fungal attachment to the brain compared
to other organs. Following the course of the infection, decrease of
the colony counts was detectable to day 7. On this day, the kidney
showed the highest number of yeast cells, followed by the fungal
burden in the brain, while the highest clearance was observable
in the spleen and the liver (Figure 2).
Histopathological examinations also indicated the presence of
C. parapsilosis yeast cells in all the examined tissues at day 2 post-
infection, when the 2 × 107 inoculation dose was used, showing
the widespread colonization of the organs via the blood vessels
(Figures 3E–H). However, no fungal cells were detected in the
harvested organs during histology analysis at day 7 post-infection
(2 × 107), or at either time points in mice infected with 1 × 107
C. parapsilosis cells (data not shown). Single cells of WT CLIB
penetrated the different sites of the spleen (Figure 3E) and liver
(Figure 3G). Colonization of the brain (Figure 3H) and the small
blood vessels of the kidney was visible at day 2 post-infection
(Figure 3F). The presence of fungal cells in the organs of the WT
CLIB-infected mice was not associated with lesions or specific
signs of immune cell infiltration. Of note, PBS-injected mice from
the same litter showed no evidence of fungal cells or immune cell
infiltrates in the examined organs (Figures 3A–D).
We also assessed the in vivo cytokine response in the colonized
neonatal organs after 1 × 107 dose of WT CLIB infection.
TNFα, IL-1β, IL-10, and KC chemokine levels were measured
from tissue homogenates of kidneys and liver, using enzyme-
linked immunosorbent assay (ELISA). We could not detect
these cytokines in spleen and brain homogenates. In the kidney,
elevated TNFα level was found at day 2 post-infection stimulated
by WT CLIB, and the quantity of this cytokine decreased at the
later time point (Figure 4A). IL-1β was also induced at day 2
post-infection and its level remained elevated at day 7. Similar to
TNFα, the secretion of KC was induced at day 2 post-infection,
and a decrease in KC production was observed at day 7.
In the liver, high amount of TNFα was triggered by the WT
CLIB at day 2 after infection. Similar to what was measured in
the kidney, a decrease in the level of this cytokine was found at
the later time point. At day 7 post-infection, an increase in the
IL-β level was measured in this organ after WT CLIB injection.
In comparison with the PBS control group, a rise in KC level
was measured at day 2 after inoculation. Also, a reduction in the
KC level was found at day 7 (Figure 4B). No significant IL-10
secretion was assessed from the kidney and liver samples after
FIGURE 5 | Fungal burden in neonatal mice after wild-type GA1 and CLIB
C. parapsilosis strains infection. CFU in spleen (A), kidney (B), and liver (C) in
newborn mice after 2 and 7 day post-infection. n = 4–5
mice/group/experiment were infected with 1 × 107/20 µl of C. parapsilosis
GA1 (WT GA1) and C. parapsilosis CLIB 214 (WT CLIB) wild-type strains.
Results (mean ± SEM) are pooled data from two independent experiments.
Not significant (ns), ∗p < 0.05 and ∗∗∗∗p < 0.0001 as determined by
Mann–Whitney U test. Republished from Perez-Garcia et al. (2016).
stimulation with WT CLIB (data not shown). The first set of
analyses confirmed the applicability of this injection method in
modeling disseminated candidiasis in neonatal mice.
The Utility of the Newborn Mice Model to
Investigate the Virulence Properties of
C. parapsilosis
We have previously reported that the GA1 and CLIB wild
type C. parapsilosis strains elicit distinct host responses during
in vitro experiments with murine and human macrophages
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FIGURE 6 | Comparison of fungal burden in the adult and neonate mice after the WT CLIB, och11/1, and och11/1+OCH1 challenge. Newborn ( × 107/20 µl) and
adult (2 × 107/100 µl) mice were infected with the C. parapsilosis CLIB 214 (WT CLIB), the cell wall mutant (och11/1) and the reintegrated (och11/1+OCH1)
strain. CFUs in spleen (A), kidney (B), and liver (C) at day 2 and 7 post-infection are shown. Results (mean ± SEM) are pooled data from two independent
experiments (n = 5 adult mice/group/experiment, neonates at least 4 mice/group/experiment). Not significant (ns), ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and
∗∗∗∗p < 0.0001 when compared to the corresponding WT CLIB infected mice group as determined by Mann–Whitney U-test.
(Toth et al., 2015). Following the inoculation of newborn mice
with these strains (infection dose 1 × 107), differences between
the two strains were detectable in terms of fungal burden
(Figure 5). At day 2 post-infection, the WT CLIB strain showed
notably higher fungal loads in the spleen, kidney and especially
in the liver, when compared to the WT GA1 strain. In contrast,
7 days after the infection, newborn mice showed higher ability
to clear the WT CLIB strain from spleen and liver. However, no
difference was found in the colony counts in the kidney.
Next, we wanted to examine the neonatal immune response
to a cell wall mutant C. parapsilosis strain (och11/1) that was
previously constructed in our laboratory (Perez-Garcia et al.,
2016). This mutant lacks the N-linked mannan outer chain in
the cell wall, and it has been shown to have a significantly
attenuated virulence in a BALB/c mouse model of systemic
infection (Perez-Garcia et al., 2016). We analyzed the fungal
burden in newborn and adult mice after injection with the
2 × 107 dose of och11/1 mutant or the wild-type WT CLIB
or the reintegrated strain (och11/1+OCH1). The virulence
differences between the wild-type and the mutant strains were
evident from the significantly decreased burdens in the spleen,
kidney and liver in both adults and pups challenged with the
och11/1 strain at 2 as well as at 7 day post-infection (Figure 6).
Neonatal mice infected with the same dose (2 × 107) of
C. parapsilosis cells displayed similar trend in organ colonization
in comparison with adult mice, as it was previously published
(Perez-Garcia et al., 2016). However, while och11/1-infected
adult mice almost completely cleared the infection by day 7,
fungal burdens in newborn mice were still high at this time
point. Infection with the lower dose (1 × 107) similarly showed
the attenuated virulence of the cell wall mutant strain with the
significantly decreased colony counts of the och11/1 in the
spleen, kidney and liver compared to the WT CLIB. Interestingly,
the fungal burdens in the brain of newborn mice were similar
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FIGURE 7 | Comparison of fungal burden in neonate mice after the 1 × 107 dose of WT CLIB, och11/1 and och11/1+OCH1 infection. Newborn (1 × 107/20 µl)
mice were infected with the C. parapsilosis CLIB 214 (WT CLIB), the cell wall mutant (och11/1) and the reintegrated (och11/1+OCH1) strain. CFUs in spleen (A),
kidney (B), liver (C), and brain (D) at day 2 and 7 post-infection are shown. Results (mean ± SEM) are pooled data from two independent experiments (n = 4
mice/group/experiment). Not significant (ns), ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001 when compared to the WT CLIB infected mice group as
determined by Mann–Whitney U-test.
following WT CLIB, och11/1, or och11/1+OCH1 challenge
(Figure 7).
Histopathological examinations indicated the presence of
och11/1, och11/1+OCH1 and wild-type C. parapsilosis yeast
cells in the brain, kidney, liver and spleen of newborn mice at day
2 post-infection, when 2x107 inoculum dose was used (Figure 8).
The cell morphology of the strains were consistent with our
previously published research (Perez-Garcia et al., 2016). The
och11/1 cells were not able to develop pseudohyphae, and the
rounded shape of the null mutant cells was distinguishable from
the elongated cell form of WT CLIB or the och11/1+OCH1
strains during the histological analysis of the tissues. Single cells
were spread in the spleen and liver of the three C. parapsilosis
strains (Figures 8B–D,J–L). In the kidney, colonization by
the fungal cells was observed around the small blood vessels
(Figures 8F–H). Colonies were present in the small foci of the
brain tissue (Figures 8N–P). However, the hematogenous spread
of the mutant and the control strains was found in the tissues,
specific signs of cellular response were generally not visible in the
organs of the pups (Figure 8).
According to the ELISA measurements, the lack of the
N-linked mannan component in the C. parapsilosis cell wall
resulted in altered cytokine response in newborn mice (infection
dose 1 × 107). In the kidney, och11/1 triggered significantly
higher TNFα production compared to the wild-type and the
reintegrated strain at the two time points of examination
(Figure 9A). IL-1β and KC secretion was markedly increased
in och11/1-challenged newborn mice at day 7 post-infection
compared to the WT CLIB, and the och11/1+OCH1-challenged
mouse groups. No significant differences were detected in the
level of TNFα and KC in the liver of WT CLIB-, och11/1-, and
och11/1+OCH1-challenged mice. However, the och11/1 strain
induced significantly less IL-1β in the liver at day 7 post-infection
compared to WT CLIB (Figure 9B). No difference was detectable
in the levels of IL-10 from the kidney and liver of the different
mouse groups (data not shown).
In conclusion, the neonatal mouse model proved to be suitable
for the study of the virulence of different C. parapsilosis strains
and compare the systemic C. parapsilosis infection in adult
and newborn mice. In addition, our results further support the
importance of the cell wall N-linked mannan in the pathogenesis
of C. parapsilosis.
DISCUSSION
Mouse models have been widely used to study human diseases.
The increased susceptibility of newborn mice and rat pups to
systemic C. albicans infection has previously been reported (Pope
et al., 1979; Domer, 1988; Trofa et al., 2011; Tsai et al., 2011).
First studies demonstrated that gastrointestinal colonization and
systemic disease could be achieved by gastric inoculation with
C. albicans in a neonatal mouse model (Pope et al., 1979;
Domer, 1988). In these studies, 5 to 6-day old mouse pups were
infected and monitored for survival. Furthermore, tissue burden
showed the colonization of spleen, kidney, liver and lung by
C. albicans strains. Therefore, these early studies demonstrated
that infant mice lend itself to study the host response against
Candida infections. In 2011, new mouse model was developed
by Tsai et al. (2011). In that model, mouse pups were infected
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FIGURE 8 | Histopathology during systemic WT CLIB, och11/1, and och11/1+OCH1 C. parapsilosis infection in neonate mice. Sections were stained with
periodic acid-Schiff (PAS) stain. Fungal cells (indicated by arrowheads) are evident in the organs of mice infected with the C. parapsilosis CLIB 214 (WT CLIB) (B
spleen, F kidney, J liver, N brain), the och11/1 (C spleen, G kidney, K liver, O brain) and the och11/1+OCH1 (D spleen, H kidney, L liver, P brain) strain. (A spleen,
E kidney, I liver, M brain) Control organs from PBS-injected mice. All observations of the infected organs were performed at day 2 of 2 × 107/20 µl dose of infection.
Scale bar represents 100 µm.
with C. albicans by intraperitoneal route on post-partum
day 2. Similarly, survival, fungal burden and histopathology
were analyzed. They showed that intraperitoneal injection of
C. albicans induced mortality in a dose-dependent fashion
and led to disseminated disease as colonization of the spleen,
kidney, liver, and lung were detected. Although this infection
method resulted in the dissemination of the fungal elements
to different organs, CFU counts were highly variable. Another
neonatal animal model was described by Trofa et al. (2011),
where 2–3 day old rat pups were infected with C. albicans and
C. parapsilosis via intragastric, intraperitoneal and intravenous
routes. In that study, colony counts demonstrated that lipase
mutants Candida strains displayed lower virulence in the
neonatal rats. In that experiment, also, C. parapsilosis infection
resulted in overall lower fungal burden compared to C. albicans.
Further investigation showed that the neonatal rat model proved
to be suitable for the testing of antifungal prophylaxis with
fluconazole, supported by significantly enhanced survival and
weight gain after coinfection with C. albicans and S. epidermidis
(Venkatesh et al., 2007). Taken together, these studies confirmed
that neonatal rodent models are useful for studying Candida
pathogenesis that may be specific to an immature host. Despite
the importance of C. parapsilosis in neonatal infections, study
of the in vivo immune response against C. parapsilosis has been
hindered by the lack of appropriate animal models. The mouse
intravenous challenge is well investigated and reproducible
model to define Candida virulence (Arendrup et al., 2002).
Therefore, here, we characterized a newborn mouse model
of intravenous C. parapsilosis infection. The first part of our
results revealed the utility of facial external vein injection
as a novel method to induce systemic Candida infection in
newborn mice. We observed widespread dissemination of the
yeast cells in the spleen, kidney, liver and brain at day 2 and 7
post-infection during CFU determination and histopathological
analysis. The benefit of the intravenous injection used in our
study is the consistency in fungal burden measurements in the
kidney, liver and spleen of newborn mice, indicating effective
colonization of these organs. The fact that the route of the
temporal vein injection was not associated with higher yeast
attachment to the brain further supported the reliability of
this model to characterize disseminated candidiasis in neonatal
mice. Furthermore, ELISA measurements demonstrated that
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FIGURE 9 | In vivo cytokine response in neonate mice after WT CLIB, och11/1, and och11/1+OCH1 C. parapsilosis infection. TNFα, IL-1β, and KC levels in the
kidney (A) and the liver (B) after day 2 and 7 post-infection. Newborn mice were infected with the lower dose of 1 × 107/20 µl with C. parapsilosis CLIB 214 (WT
CLIB), the cell wall mutant (och11/1), the reintegrated (och11/1+OCH1) strains or with 20µl of PBS (control group, ctrl). Results (mean ± SEM) are pooled data
from at least two independent experiments (at least 4 mice/group/experiment). Not significant (ns), ∗p < 0.05, ∗∗p < 0.01, when it was compared to the wild-type
C. parapsilosis infected mice group determined by unpaired t-test.
C. parapsilosis infection induced increased TNFα, IL-1β, and KC
secretion in the kidney and liver in newborn mice. Therefore, the
route of the injection and the features of this neonatal mouse
model grant the opportunity to compare the susceptibility of
neonate mice to the different C. parapsilosis strains and analyze
the induced immune response in the adult and the neonatal
settings during systemic infections.
In this research, we tested the utility of the neonatal
candidiasis model to analyze the pathogenic properties of
the different C. parapsilosis strains. Previously, it has been
demonstrated that different isolates of this species trigger various
host cell responses (Toth et al., 2015). It has been shown that
macrophage migration is significantly enhanced toward WT
CLIB than toward the WT GA1 strain. Furthermore, both
murine macrophages and human PBMC-DMs require more
time to engulf WT CLIB cells than WT GA1 cells. The altered
cellular immune responses have been suggested to originate from
potential differences in the cell wall structure or composition
and fungal signaling molecules released by the two strains
(Toth et al., 2015). In the present study, fungal burden results
reflected the differences in the virulence properties of the two
isolates. Compared to WT GA1, WT CLIB infection led to
higher colonization of spleen, kidney, and liver at the early
time point of infection. However, clearance by the neonatal host
was more effective against the WT CLIB strain, as the WT
GA1 showed higher tissue burden in the spleen and liver at
7 day after the infection. According to the study of Trofa et al.
(2011), C. parapsilosis GA1 strain inoculation of rat pups did
not induce mortality and the intragastric and intraperitoneal
inoculation with 1 × 107 cells of this pathogen led to complete
clearance by the used host model organism on day 6. Similarly,
during our experiments, infection of neonatal mice with the
two C. parapsilosis isolates was not associated with mortality
and the colonization showed decreased fungal burdens overtime.
Therefore, these results contribute to a deeper insight into
C. parapsilosis infection in the neonatal animal settings.
The N-linked mannosylation has recently been shown to
play a role in the virulence of C. parapsilosis (Perez-Garcia
et al., 2016). Disruption of C. parapsilosis OCH1 results in
morphological changes and decreased fungal load in the mouse
model of systemic candidiasis. Our data support these results
by the significantly reduced fungal burdens in the spleen,
kidney and liver of newborn mice after even the lower dose
(1 × 107) or the higher dose (2 × 107) of the och11/1 stimulus
compared to the wild-type strain. No significant difference was
detected in the colony counts in the brain between the wild-
type and the cell wall mutant strain infected groups. In vitro
studies with C. albicans demonstrated the invasion of brain
endothelial cells by trans-cellular migration and the role of fungal
invasins, Als3 and Ssa1 mediated trafficking to the brain (Jong
et al., 2001; Liu et al., 2011). Therefore, our results indicate
that the N-mannan component in the cell wall structure may
not affect the mechanism of how C. parapsilosis enters and
colonizes the brain of mice. Future research could target the
investigations of how other Candida spp. invade brain tissue from
the circulation.
During the histopathological analysis, yeast cells of the less
virulent cell wall mutant, as well as the wild-type strain were
present in the organs without specific damage of the tissues or
visible cellular changes after the 2 × 107 dose of the infection.
This phenomenon likely relates to the route of infection and to
the inoculation dose, and may also be influenced by the early
developmental stage of the animal, as no evidence of yeast cells
were detected at the lower dose of the infection.
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Perez-Garcia et al. (2016) have shown that C. parapsilosis N-
and O-linked mannans play different roles in host response than
C. albicans mannans. C. albicans cells lacking N-linked mannosyl
residues induced lower levels of inflammatory cytokines in
human mononuclear cells and significantly decreased TNFα and
IL-6 in kidneys in infected mice (Netea et al., 2006). In contrast,
IL-6, IL-10, TNFα, and IL-1β production by human PBMCs
was found to be higher following incubation with och11/1
compared to the wild-type C. parapsilosis strain (Perez-Garcia
et al., 2016). Here, we found increased TNFα, IL-1β, and KC
secretion in the kidney of och11/1-injected neonate mice, which
result correlates with the previous findings in human PBMCs
(Perez-Garcia et al., 2016). The liver showed slightly elevated
TNFα as well, but we found decreased IL-1β and KC level
after the cell wall mutant infection. Preceding research with
glycosylation mutant C. albicans strains reported the varying
chemokine or cytokine responses between tissues (spleen and
kidney) from infected mice (Castillo et al., 2011). Thus, despite
the mentioned differences between the kidney and liver in our
research, cytokine measurements stimulated by the och11/1
correlates with the significantly decreased fungal burden. As
the neonatal host showed less susceptibility against the cell wall
mutant strain, the higher KC chemokine and TNFα could explain
the higher activation of the immune cells, which contributed to
the more effective clearance of the och11/1. Taken together, our
model has proven useful for studying the role of the cell wall
elements during the host-pathogen interactions and our findings
further strengthened the importance of N-linked mannosylation
in the virulence of C. parapsilosis.
CONCLUSION
In our results confirm that injection via the external facial vein is
a reliable and efficient method to induce disseminated Candida
infection in newborn mouse. Therefore, for the future studies
this novel model will be an adequate tool to compare the host
responses of adult and newborn mice and will be useful for the
analysis the pathogenic features of the different Candida strains
in the neonatal host system. This model may also allow for
testing of novel therapeutic strategies against systemic neonatal
candidiasis.
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